Global Specialty President Appointment Recent hire of Claus Jepsen as President, Global Specialty, indicates Lupin's focus on expanding market presence and diversifying product offerings.
New Product Launches Lupin's recent launch of generic medications like Pred Forte Ophthalmic Suspension and Mybetriq variants in the US market presents sales opportunities for healthcare providers and pharmacies.
Partnerships for Market Expansion Collaborations with companies like Scope Eye Care and Takeda signify Lupin's strategic approach to entering new markets and strengthening distribution networks, providing potential avenues for sales growth.
Innovative Product Offerings The introduction of Fesoterodine Fumarate and generic cancer treatment drugs showcases Lupin's commitment to innovation, offering unique solutions that can appeal to a wide range of healthcare professionals, creating sales prospects.
Competitive Positioning and Market Reach With revenue in the range of $100M - 1B, Lupin competes among other major pharmaceutical companies, signaling a significant market presence that presents opportunities for strategic partnerships and increased sales volumes.
6.3K
$100M$1B
13K$1B
11K$1B
154K$1B
44K$1B
27K$1B
16K$1BLupin Pharmaceuticals uses 8 technology products and services including Google Ads, Linkedin Ads, SuccessFactors, and more. Explore Lupin Pharmaceuticals's tech stack below.
| Lupin Pharmaceuticals Email Formats | Percentage |
| FirstLast@lupin.com | 96% |
| FirstLas@lupin.com | 2% |
| FirLast@lupin.com | 1% |
| FirstL@lupin.com | 1% |
Pharmaceutical ManufacturingNew Jersey, United States1001-5000 Employees
Lupin is the U.S. wholly-owned subsidiary of Lupin Limited, which is among the top pharmaceutical companies in India. Through our sales and marketing headquarters in Baltimore, MD Lupin is dedicated to delivering high-quality, branded and generic medications trusted by healthcare professionals and patients across geographies.
Company Overview
Media & News
Funding & FinancialsLupin Pharmaceuticals's revenue is in the range of $100M$1B
Funding & FinancialsLupin Pharmaceuticals's revenue is in the range of $100M$1B
1-888-653-2347 
support@leadiq.com